News
3h
Zacks Investment Research on MSNAMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes LingerAmgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...
4d
TipRanks on MSNMerck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by AnalystsAnalysts are intrested in these 5 stocks: ( ($MRK) ), ( ($REGN) ), ( ($CLRB) ), ( ($HUMA) ) and ( ($FL) ). Here is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results